-
Awarded06/08/2026
-
Today14/09/2026
Utilities
- indicates text translated automatically in your browsing language
Contract award notice pursuant to Article 266a(5)(3) of the Medicinal Products in Human Medicine Act, in conjunction with Article 1(1)(2), Article 3(3), Article 15c(1) and Article 15b of Regulation № 10/17.11.2011 of the Ministry of Health
Contract award notice pursuant to Article 266a(5)(3) of the Medicinal Products in Human Medicine Act, in conjunction with Article 1(1)(2), Article 3(3), Article 15c(1) and Article 15b of Regulation № 10/17.11.2011 of the Ministry of Health. After receiving a letter of agreement from the Bulgarian Drug Agency (BDA) and a written request for the supply of the following medicinal product, the Contractor agrees to supply the following medicinal product in the quantities prescribed by St. Ivan Rilski University Hospital EAD by means of a protocol – Annex № 1 (whichever is applicable), issued in accordance with Ordinance № 10 / 17.11.2011, on the basis of an offer from the CONTRACTOR. - International non-proprietary name: Lomustine Capsules 40mg, BELUSTINE 40MG CAPS x 10'S, MEONE HEALTHCARE PVT LTD, capsules , 40mg, tablets, number of dosage forms in a package 10 caps, quantity of packages -10;
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.